Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,644,974
+$2,693,658 QoQ
Shares Held
45,360
+20.7% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#177
of 772 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 19%
Shared 0%
None 81%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $43,412,538 across 29 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (17.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
121,151 | $8,705,910 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
45,360 | $7,644,974 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
9,855 | $5,339,734 | |
| 4 | VTRS |
Viatris Inc
|
197,717 | $3,139,745 | |
| 5 | HLN |
Haleon plc
|
263,202 | $2,455,674 | |
| 6 | HROW |
Harrow, Inc.
|
56,414 | $2,395,902 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
143,998 | $2,308,287 | |
| 8 | ALKS |
Alkermes plc.
|
42,278 | $2,215,367 |
All Filings in NBIX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,644,974 | 45,360 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,951,316 | 37,584 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,386,518 | 30,928 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,937,799 | 28,051 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $1,530,401 | 12,176 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $808,486 | 7,310 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,589,406 | 11,644 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,130,077 | 9,808 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,343,108 | 9,756 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $1,125,151 | 8,158 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,558,852 | 11,831 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $391,050 | 3,476 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $281,296 | 2,983 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $291,817 | 2,883 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $351,870 | 2,946 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $204,879 | 1,929 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $162,206 | 1,664 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $130,687 | 1,394 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $127,669 | 1,499 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $121,517 | 1,267 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $120,287 | 1,236 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $100,264 | 1,031 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||